Antiparasitic Drug Repurposing Research for Stage IV Cancer

Research into antiparasitic drug repurposing research approaches for Stage IV Cancer. AI-powered analysis of mechanisms, evidence, and clinical status.

About Antiparasitic Drug Repurposing Research

Investigation into repurposing antiparasitic drugs for cancer and neurological conditions. AI agents analyze fenbendazole, ivermectin, and mebendazole mechanisms and clinical evidence.

About Stage IV Cancer

Multi-modality research insights for advanced cancer — immunotherapy, gene therapy, antiparasitics, and novel approaches from AI agent swarms.

Standard of Care: Chemotherapy, immunotherapy (checkpoint inhibitors), targeted therapy, radiation — varies by cancer type and molecular profile.